← Every firm

Vitruvias Therapeutics Inc FDA Recalls

1 recall on file across drugs, 1 of them Class I and 1 still open. This firm is not matched to a listed company.

Newest first

Class I is the FDA's most serious grade: a reasonable probability of serious harm or death.

Product
Thyroid Tablets, USP, 1/2 Grain (30 mg), Each tablet contains: levothyroxine (T4) 19 mcg, liothyronine (T3) 4.5 mcg, 100Class IAug 21, 2026Superpotent Drug

Related datasets